Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2025-12-30 @ 11:38 AM
Study NCT ID:
NCT05317403
Status:
RECRUITING
Last Update Posted:
2024-11-26
First Post:
2022-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Venetoclax to Augment Epigenetic Modification and Chemotherapy
Sponsor:
Medical College of Wisconsin
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-31
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-03-08
First Submit QC Date:
None
Study First Post Date:
2022-04-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-22
Last Update Post Date:
2024-11-26
Last Update Post Date Type:
ACTUAL